SCHEMBL16633307

SCHEMBL16633307

CC(C)(C)N(C(=O)O)C(COC(F)F)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
EPHX1 P07099 2/20 0.36
SERPINE1 P05121 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
EPHX2 P34913 2/20 0.35
NR1H4 Q96RI1 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
PDE2A O00408 1/20 0.34
POLB P06746 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16633980 0.85 ALDH1A1 (0.41) ALDH1A1MMP2MMP9PPARAEPHX1
SCHEMBL16634078 0.84 EPHX1 (0.40) ALDH1A1MMP2MMP9EPHX1SERPINE1
SCHEMBL16633204 0.82 MMP2 (0.40) ALDH1A1MMP2MMP9EPHX1SERPINE1
SCHEMBL16632995 0.81 EPHX1 (0.41) ALDH1A1MMP2MMP9PPARGPPARD
SCHEMBL16633428 0.81 ALDH1A1 (0.38) ALDH1A1MMP2MMP9PPARGPPARD
SCHEMBL16633172 0.81 ALDH1A1 (0.38) ALDH1A1MMP2MMP9EPHX1SERPINE1
SCHEMBL16633119 0.78 SLC6A4 (0.47) EPHX2OPRM1
SCHEMBL16563726 0.76 TRPV1 (0.40) ALDH1A1EPHX1SERPINE1EPHX2NR1H4
SCHEMBL16633600 0.75 MMP2 (0.46) ALDH1A1MMP2MMP9EPHX1SERPINE1
SCHEMBL16633449 0.75 ALDH1A1 (0.39) ALDH1A1PPARGPPARDPPARAEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9469637-B2 Nitrogenated heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-10-18 US disclosed
US-20150105373-A1 NITROGENATED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105373-A1 NITROGENATED HETEROCYCLIC COMPOUND PDE2A, PDE5A, PDE3A ALDH1A1 492/4885MMP2 860/4885MMP9 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.